+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Renal Anemia Drug"

Anemia in Chronic Kidney Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Anemia in Chronic Kidney Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 131 Pages
  • Global
From
Renal Anemia - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Renal Anemia - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Anemia In Chronic Kidney Disease - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Anemia In Chronic Kidney Disease - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Renal Anemia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Renal Anemia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Renal Anemia - Pipeline Insight, 2024 - Product Thumbnail Image

Renal Anemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Renal Anemia Therapeutics Market 2024-2028 - Product Thumbnail Image

Renal Anemia Therapeutics Market 2024-2028

  • Report
  • January 2024
  • 160 Pages
  • Global
From
Renal Anemia Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Renal Anemia Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • October 2024
  • 78 Pages
  • Global
From
Anemia in Chronic Kidney Disease (Renal Anemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Anemia in Chronic Kidney Disease (Renal Anemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 99 Pages
  • Global
From
Chemotherapy Induced Anemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Chemotherapy Induced Anemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • May 2022
  • 51 Pages
  • Global
From
  • 9 Results (Page 1 of 1)
Loading Indicator

The Renal Anemia Drug market is a subset of the Hematological Drugs market, which includes drugs used to treat diseases related to the blood and blood-forming organs. Renal Anemia Drugs are used to treat anemia caused by chronic kidney disease, a condition in which the kidneys are unable to produce enough of a hormone called erythropoietin (EPO). EPO is responsible for stimulating the production of red blood cells, which carry oxygen throughout the body. Renal Anemia Drugs are typically administered intravenously or subcutaneously, and may include recombinant human EPO, iron supplements, and other drugs. Some companies in the Renal Anemia Drug market include Amgen, Roche, Novartis, Pfizer, and Johnson & Johnson. Show Less Read more